List of Tables
Table 1. Global Tenofovir Disoproxil Fumarate Tablets Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Tenofovir Disoproxil Fumarate Tablets Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Tenofovir Disoproxil Fumarate Tablets Market Competitive Situation by Manufacturers in 2025
Table 4. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Tenofovir Disoproxil Fumarate Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Tenofovir Disoproxil Fumarate Tablets Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Tenofovir Disoproxil Fumarate Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Tenofovir Disoproxil Fumarate Tablets, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Tenofovir Disoproxil Fumarate Tablets, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Tenofovir Disoproxil Fumarate Tablets, Product Types and Applications
Table 12. Global Key Manufacturers of Tenofovir Disoproxil Fumarate Tablets, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tenofovir Disoproxil Fumarate Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tenofovir Disoproxil Fumarate Tablets Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tenofovir Disoproxil Fumarate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (K Units), 2021–2026
Table 18. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Region (2021–2026)
Table 19. Global Tenofovir Disoproxil Fumarate Tablets Sales by Region (K Units), 2027–2032
Table 20. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Region (2027–2032)
Table 21. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region (US$ Million), 2021–2026
Table 22. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region (2021–2026)
Table 23. Global Tenofovir Disoproxil Fumarate Tablets Revenue by Region (US$ Million), 2027–2032
Table 24. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region (2027–2032)
Table 25. North America Tenofovir Disoproxil Fumarate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2021–2026
Table 27. North America Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2027–2032
Table 28. North America Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2021–2026
Table 29. North America Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2021–2026
Table 32. Europe Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2027–2032
Table 33. Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Tenofovir Disoproxil Fumarate Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Tenofovir Disoproxil Fumarate Tablets Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Tenofovir Disoproxil Fumarate Tablets Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Tenofovir Disoproxil Fumarate Tablets Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Tenofovir Disoproxil Fumarate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2021–2026
Table 42. Latin America Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2027–2032
Table 43. Latin America Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Revenue by Country (US$ Million), 2027–2032
Table 50. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units) by Type (2021–2026)
Table 51. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units) by Type (2027–2032)
Table 52. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Type (2021–2026)
Table 53. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Type (2027–2032)
Table 54. Global Tenofovir Disoproxil Fumarate Tablets Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Tenofovir Disoproxil Fumarate Tablets Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Type (2021–2026)
Table 57. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Type (2027–2032)
Table 58. Global Tenofovir Disoproxil Fumarate Tablets Price (US$/Unit) by Type (2021–2026)
Table 59. Global Tenofovir Disoproxil Fumarate Tablets Price (US$/Unit) by Type (2027–2032)
Table 60. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units) by Application (2021–2026)
Table 61. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units) by Application (2027–2032)
Table 62. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Application (2021–2026)
Table 63. Global Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Application (2027–2032)
Table 64. Global Tenofovir Disoproxil Fumarate Tablets Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Tenofovir Disoproxil Fumarate Tablets Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Application (2021–2026)
Table 67. Global Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Application (2027–2032)
Table 68. Global Tenofovir Disoproxil Fumarate Tablets Price (US$/Unit) by Application (2021–2026)
Table 69. Global Tenofovir Disoproxil Fumarate Tablets Price (US$/Unit) by Application (2027–2032)
Table 70. Gilead Sciences Company Information
Table 71. Gilead Sciences Description and Business Overview
Table 72. Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Gilead Sciences Tenofovir Disoproxil Fumarate Tablets Product
Table 74. Gilead Sciences Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. GSK Tenofovir Disoproxil Fumarate Tablets Product
Table 79. GSK Recent Developments/Updates
Table 80. Teva Pharmaceuticals Company Information
Table 81. Teva Pharmaceuticals Description and Business Overview
Table 82. Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Teva Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product
Table 84. Teva Pharmaceuticals Recent Developments/Updates
Table 85. Strides Pharma Company Information
Table 86. Strides Pharma Description and Business Overview
Table 87. Strides Pharma Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Strides Pharma Tenofovir Disoproxil Fumarate Tablets Product
Table 89. Strides Pharma Recent Developments/Updates
Table 90. Hetero Drugs Company Information
Table 91. Hetero Drugs Description and Business Overview
Table 92. Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Hetero Drugs Tenofovir Disoproxil Fumarate Tablets Product
Table 94. Hetero Drugs Recent Developments/Updates
Table 95. Aurobindo Pharma Company Information
Table 96. Aurobindo Pharma Description and Business Overview
Table 97. Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Aurobindo Pharma Tenofovir Disoproxil Fumarate Tablets Product
Table 99. Aurobindo Pharma Recent Developments/Updates
Table 100. Shanghai Haini Pharmaceutical Company Information
Table 101. Shanghai Haini Pharmaceutical Description and Business Overview
Table 102. Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Shanghai Haini Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 104. Shanghai Haini Pharmaceutical Recent Developments/Updates
Table 105. Zhejiang Sukean Pharmaceutical Company Information
Table 106. Zhejiang Sukean Pharmaceutical Description and Business Overview
Table 107. Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Zhejiang Sukean Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 109. Zhejiang Sukean Pharmaceutical Recent Developments/Updates
Table 110. Chongqing Yaoyou Pharmaceutical Company Information
Table 111. Chongqing Yaoyou Pharmaceutical Description and Business Overview
Table 112. Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Chongqing Yaoyou Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 114. Chongqing Yaoyou Pharmaceutical Recent Developments/Updates
Table 115. Beijing SL Pharmaceutical Company Information
Table 116. Beijing SL Pharmaceutical Description and Business Overview
Table 117. Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 119. Beijing SL Pharmaceutical Recent Developments/Updates
Table 120. Qilu Pharmaceutical Company Information
Table 121. Qilu Pharmaceutical Description and Business Overview
Table 122. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 124. Qilu Pharmaceutical Recent Developments/Updates
Table 125. Chia Tai Tianqing Pharmaceutical Company Information
Table 126. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 127. Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Chia Tai Tianqing Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 129. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 130. Luoxin Pharmaceuticals Company Information
Table 131. Luoxin Pharmaceuticals Description and Business Overview
Table 132. Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Luoxin Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product
Table 134. Luoxin Pharmaceuticals Recent Developments/Updates
Table 135. Shijiazhuang Lonzeal Pharmaceuticals Company Information
Table 136. Shijiazhuang Lonzeal Pharmaceuticals Description and Business Overview
Table 137. Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Shijiazhuang Lonzeal Pharmaceuticals Tenofovir Disoproxil Fumarate Tablets Product
Table 139. Shijiazhuang Lonzeal Pharmaceuticals Recent Developments/Updates
Table 140. Haisco Pharmaceutical Company Information
Table 141. Haisco Pharmaceutical Description and Business Overview
Table 142. Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Haisco Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 144. Haisco Pharmaceutical Recent Developments/Updates
Table 145. Sichuan Kelun Pharmaceutical Company Information
Table 146. Sichuan Kelun Pharmaceutical Description and Business Overview
Table 147. Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Sichuan Kelun Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 149. Sichuan Kelun Pharmaceutical Recent Developments/Updates
Table 150. Chengdu Beite Pharmaceutical Company Information
Table 151. Chengdu Beite Pharmaceutical Description and Business Overview
Table 152. Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chengdu Beite Pharmaceutical Tenofovir Disoproxil Fumarate Tablets Product
Table 154. Chengdu Beite Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Tenofovir Disoproxil Fumarate Tablets Distributors List
Table 158. Tenofovir Disoproxil Fumarate Tablets Customers List
Table 159. Tenofovir Disoproxil Fumarate Tablets Market Trends
Table 160. Tenofovir Disoproxil Fumarate Tablets Market Drivers
Table 161. Tenofovir Disoproxil Fumarate Tablets Market Challenges
Table 162. Tenofovir Disoproxil Fumarate Tablets Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tenofovir Disoproxil Fumarate Tablets
Figure 2. Global Tenofovir Disoproxil Fumarate Tablets Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Tenofovir Disoproxil Fumarate Tablets Market Share by Type: 2025 & 2032
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Tenofovir Disoproxil Fumarate Tablets Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Tenofovir Disoproxil Fumarate Tablets Market Share by Application: 2025 & 2032
Figure 8. HIV-1 Infection
Figure 9. Chronic Hepatitis B
Figure 10. Global Tenofovir Disoproxil Fumarate Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Tenofovir Disoproxil Fumarate Tablets Market Size (US$ Million), 2021–2032
Figure 12. Global Tenofovir Disoproxil Fumarate Tablets Sales (K Units), 2021–2032
Figure 13. Global Tenofovir Disoproxil Fumarate Tablets Average Price (US$/Unit), 2021–2032
Figure 14. Tenofovir Disoproxil Fumarate Tablets Report Years Considered
Figure 15. Tenofovir Disoproxil Fumarate Tablets Sales Share by Manufacturers in 2025
Figure 16. Global Tenofovir Disoproxil Fumarate Tablets Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Tenofovir Disoproxil Fumarate Tablets Players: Market Share by Revenue in Tenofovir Disoproxil Fumarate Tablets in 2025
Figure 18. Tenofovir Disoproxil Fumarate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Tenofovir Disoproxil Fumarate Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021–2032)
Figure 21. North America Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Country (2021–2032)
Figure 22. United States Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021–2032)
Figure 25. Europe Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Country (2021–2032)
Figure 26. Germany Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Region (2021–2032)
Figure 33. China Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021–2032)
Figure 41. Latin America Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Tenofovir Disoproxil Fumarate Tablets Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Tenofovir Disoproxil Fumarate Tablets Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Tenofovir Disoproxil Fumarate Tablets by Type (2021–2032)
Figure 52. Global Revenue Market Share of Tenofovir Disoproxil Fumarate Tablets by Type (2021–2032)
Figure 53. Global Tenofovir Disoproxil Fumarate Tablets Price (US$/Unit) by Type (2021–2032)
Figure 54. Global Sales Market Share of Tenofovir Disoproxil Fumarate Tablets by Application (2021–2032)
Figure 55. Global Revenue Market Share of Tenofovir Disoproxil Fumarate Tablets by Application (2021–2032)
Figure 56. Global Tenofovir Disoproxil Fumarate Tablets Price (US$/Unit) by Application (2021–2032)
Figure 57. Tenofovir Disoproxil Fumarate Tablets Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
